Acute Promyelocytic Leukaemia With PML – RAR α Fusion Presenting as Pancytopenia and Atypical Morphology – A Case Report
Acute promyelocytic leukemia with peculiar presentation.
Abstract
Acute myeloid leukaemia (AML) is characterised by uncontrolled proliferation of malignant marrow stem cells and is associated with infection, anaemia and bleeding. An improved understanding of pathophysiology has led to revamping the diagnostic, prognostic and therapeutic landscape of AML. AML is classified based on the defined genetic abnormalities and based on the differentiation. AML with predominance of abnormal promyelocytes shows characteristic t(15;17)(q24.1;q21.2) leading to promyelocytic leukaemia – retinoic acid receptor alpha (PML – RARA) fusion oncoprotein. A 75-year-old male with features of acute promyelocytic leukaemia – hypogranular variant with atypical morphology and PML-RARA fusion is presented. The bilobed buttock shaped nuclei is an atypical presentation and is important to diagnose this morphology.
References
Cull EH, Altman JK. Contemporary treatment of APL. Curr Hematol Malig Rep. 2014 Jun;9(2):193-201. doi: 10.1007/s11899-014-0205-6.
Douer D, Martin SP, Chang E, Nichols PW, Watkins KJ, Levine AM. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood. 1996 Jan 1;87(1):308-13. PMID: 8547657.
Cervera J, Montesinos P, Hernández-Rivas JM, Calasanz MJ, Aventín A, Ferro MT, et al. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Haematologica. 2010 Mar;95(3):424-31. doi: 10.3324/haematol.2009.013243.
McDonnell MH, Smith ET Jr, Lipford EH, Gerber JM, Grunwald MR. Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype. Hematol Oncol Stem Cell Ther. 2017 Mar;10(1):35-8. doi: 10.1016/j.hemonc.2015.12.004.
Singh T. Atlas and text of hematology. 4th ed. Sirmaur: Avichal; 2018. pp. 265-268.
Tran VT, Phan TT, Mac HP, Tran TT, Ho TT, Pho SP, et al. The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia. BMC Res Notes. 2020 Aug 26;13(1):394. doi: 10.1186/s13104-020-05235-7.
Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).